Semathera - Crunchbase Company Profile & Funding

Q: Where is Semathera's headquarters?

Semathera is located in Westmount, Quebec, Canada.

Q: Who invested in Semathera?

Semathera has 2 investors including Amorchem And Senju Pharmaceutical.

Q: When was the last funding round for Semathera?

Semathera closed its last funding round on obfuscated from a Venture - Series Unknown round.

Q: How much funding has Semathera raised to date?

Semathera has raised obfuscated.

Overview

Semathera

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Events

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Semathera

CB Rank

136853

SemaThera is a spin-off company from AmorChem Venture Fund 1

Founded

obfuscation

Private

Venture - Series Unknown

Westmount, Quebec, Canada

1-10

semathera.com

Biotechnology

Diabetes

Therapeutics

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Seed

OBF

obfuscation

Key People

Przemyslaw Sapieha: Founder and Chief Scientific Officer
Garth Cumberlidge: President, Director, and Chief Executive Office
Past Role: Mimetogen Pharmaceuticals, Co-Founder, President and CEO

Details

Legal Name

SemaThera Inc.

Operating Status

Active

Company Type

For Profit

Founders

Przemyslaw Sapieha

About the Company

SemaThera is a spin-off company from AmorChem Venture Fund 1, focusing on SEMA 3A protein inhibitor in the treatment of ocular diseases, such as diabetic macular edema. This technology emerges from the laboratory of Dr Mike Sapieha, Hôpital Maisonneuve-Rosement (Montreal, Canada).

Contact Email

info@semathera.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

ST-102

A bispecific recombinant protein trap that binds and neutralizes both VEGF and Semaphorin 3A to treat diabetic macular edema and other retinal vascular diseases.

Anti-Semaphorin 3A Antibody

A humanized antibody that specifically binds Semaphorin 3A to inhibit its role in diabetic macular edema and other diabetic complications.

Research & Development

Semathera is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Semathera	2	obfuscated obfuscation	Amorchem, Senju Pharmaceutical	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Semathera	2	obfuscated obfuscation	Amorchem, Senju Pharmaceutical	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Semathera	2	obfuscated obfuscation	Amorchem, Senju Pharmaceutical	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Semathera	2	obfuscated obfuscation	Amorchem, Senju Pharmaceutical	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Semathera	2	obfuscated obfuscation	Amorchem, Senju Pharmaceutical	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Semathera	2	obfuscated obfuscation	Amorchem, Senju Pharmaceutical	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Semathera	2	obfuscated obfuscation	Amorchem, Senju Pharmaceutical	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Semathera	2	obfuscated obfuscation	Amorchem, Senju Pharmaceutical	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Semathera	2	obfuscated obfuscation	Amorchem, Senju Pharmaceutical	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Semathera	2	obfuscated obfuscation	Amorchem, Senju Pharmaceutical	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Amorchem	Yes	Venture Round - Semathera	Elizabeth Douville
Amorchem	Yes	Venture Round - Semathera	Elizabeth Douville
Amorchem	Yes	Venture Round - Semathera	Elizabeth Douville
Amorchem	Yes	Venture Round - Semathera	Elizabeth Douville
Amorchem	Yes	Venture Round - Semathera	Elizabeth Douville